-Reuters
Vivos Therapeutics Announces Pricing Of $4M Private Placement Priced At-the-Market Under Nasdaq Rules
Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild-to-moderate